Logo
Login
$INKT
$10.80 +$0.17 (1.6%) Close

Ownership

13F as of Q2 2026 · 5.1M shares outstanding

Who owns INKT?

By type of holder
Institutions 100.0% Insiders 0.0% Everyone else 0.0%
Concentration Top 10 holders own 217.2%
BlackRock, Inc. 61.7% · T. Rowe Price Investment Management, Inc. 34.2%
Institutional ownership
100.0%
0 pts vs last qtr
Institutional holders
233
+7 vs last qtr
Net shares bought
+739.8K
by institutions in Q2 2026
New / sold out
34 / 27
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • TSP Capital Management Group, LLC NEW +211.0K
  • Jupiter Topco LLC NEW +129.3K

Sign up to see all 5.

Biggest sellers in Q2 2026
  • Jane Street Group, LLC −82.2K
  • HRT Financial LP SOLD OUT −67.5K

Sign up to see all 5.

Who is planning to sell?

Notices of proposed sale, last 12 months
$73.3K
1 notice from 1 person
Shares covered
6.9K
0.14% of the company
Arranged in advance
0%
of the value is under a 10b5-1 plan
Under a 10b5-1 plan No plan
$0$36.6K$73.3KNovDecJanFebMarAprMayJunJulAugSepOct 2026: $73.3K without a planOct
Largest proposed sellers
  • Buell Jennifer Officer $73.3K
Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2021–FY2025
+64.1%
+13.18% a year
Each share's claim on the business
−39.1%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
— vs $13.1M
over 5 fiscal years
Diluted shares, split-adjusted
2.5M3.4M4.3M2021: 2.6M shares'212022: 3.4M shares'222023: 3.4M shares'232024: 3.8M shares'242025: 4.3M shares'25
Buybacks Stock-based comp
$0$1.9M$3.9M2021 buybacks: $02021 stock comp: $1.7M'212022 buybacks: $02022 stock comp: $3.0M'222023 buybacks: $02023 stock comp: $3.9M'232024 buybacks: $02024 stock comp: $1.8M'242025 buybacks: $02025 stock comp: $2.7M'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years63% 3–5 years13% 1–3 years7% Under 1 year17%
Quarterly turnover
6.4%
of institutional shares changed hands
Top 10 managers, median time held
5 years

Super Investors

Investment managers reporting INKT on Form 13F
B
BlackRock, Inc.
Shares
3.1M
% of company
61.69%
Change vs last qtr
+125.0K (+4.1%)
Held since
≤2021
TR
T. Rowe Price Investment Management, Inc.
Shares
1.7M
% of company
34.23%
Change vs last qtr
+4.5K (+0.3%)
Held since
2023

28 more super investors behind a free account

See every manager holding Mink Therapeutics Inc, how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting INKT on Form N-PORT; together they hold 162.3% of the company
IC
iShares Core S&P Small-Cap ETF
iShares Trust
Position value
$63M
% of company
21.99%
% of the fund
0.06%
As of
June 30, 2026
NG
Neuberger Genesis Fund
Neuberger Berman Equity Funds
Position value
$58.1M
% of company
19.64%
% of the fund
0.80%
As of
August 31, 2026

23 more funds behind a free account

See every fund holding Mink Therapeutics Inc and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
WU
Wiinberg Ulf
Insider
Shares
79.6K
% of company
1.56%
Change vs last qtr
—
Held since
—
BJ
Buell Jennifer
Insider
Shares
74.2K
% of company
1.45%
Change vs last qtr
—
Held since
—

7 more holders behind a free account

See every insider and 5%+ holder of Mink Therapeutics Inc.

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support
View Pricing Plans